Therapeutic areas

More filters

Favourite

Popular

Promote

Welcome to Servier's content hub for healthcare professionals

Trending

Cardiometabolism 16.01.2025

My Health Partner, the ideal partner to help patients understand their disease better and improve their everyday lifestyle! Learn more

My Health Partner, the ideal partner to help patients understand their disease better and improve their everyday lifestyle!

0:29

Trending

CardiometabolismOncologyVenous Disease 03.06.2025

Welcome to My Servier Middle East Portal Learn more

Welcome to My Servier Middle East Portal

0:54

Discover more articles, guidelines and events.

Show: Favourite Popular Promoted

Filters

Indapamide-Based Treatment Evidence Beyond BP Reduction

Explore the pooled analysis of four trials evaluating indapamide, mostly combined with perindopril, and its impact on mortality and cardiovascular outcomes.

Cardiometabolism 16.09.2026

Indapamide-Based Treatment Evidence Beyond BP Reduction

Reducing Cardiovascular Mortality: New Insights from the Experts

Prof. Martin Strauss and Prof. Stefano Masi discuss new insights into cardiovascular mortality reduction and the evidence around antihypertensive treatment strategies.

Cardiometabolism 16.09.2026

Reducing Cardiovascular Mortality: New Insights from the Experts

Perindopril/Amlodipine in Hypertension: Expert Clinical Perspectives

Prof. Luis Alcocer and Prof. Stefano Masi share their clinical perspectives on hypertension management and the role of the perindopril/amlodipine combination in achieving effective BP control.

Cardiometabolism 16.09.2026

Perindopril/Amlodipine in Hypertension: Expert Clinical Perspectives

24-Hour BP Control: Why Blood Pressure Variability Matters

Prof. Anna Vachulová discusses the importance of 24-hour BP control and long-term BP variability, and how the perindopril/amlodipine combination contributes to sustained BP management.

Cardiometabolism 16.09.2026

24-Hour BP Control: Why Blood Pressure Variability Matters

Perindopril: Cardiovascular Protection Across the Hypertension Continuum

Perindopril: Cardiovascular Protection Across the Hypertension Continuum

Cardiometabolism 16.09.2026

Perindopril: Cardiovascular Protection Across the Hypertension Continuum

ACE Inhibitors and Cough: What Is the Real Burden?

ACE Inhibitors and Cough: What Is the Real Burden?

Cardiometabolism 16.09.2026

ACE Inhibitors and Cough: What Is the Real Burden?

Reaching LDL-C Targets in Dyslipidemia What Do the Guidelines Recommend?

Reaching LDL-C Targets in Dyslipidemia: What Do the Guidelines Recommend?

Cardiometabolism 16.09.2026

Reaching LDL-C Targets in Dyslipidemia What Do the Guidelines Recommend?

Diabetes and Ramadan Global Survey: Fasting Outcomes with Modern Sulfonylureas

Cardiometabolism 16.09.2026

Diabetes and Ramadan Global Survey: Fasting Outcomes with Modern Sulfonylureas

Comparative effectiveness of Gliclazide MR and Sitagliptin

Comparative effectiveness of Gliclazide MR and Sitaglibtin

Cardiometabolism 15.09.2026

Comparative effectiveness of Gliclazide MR and Sitagliptin

Lipocomb synergistic mode of action

Lipocomb synergistic mode of action

Cardiometabolism 15.09.2026

Lipocomb synergistic mode of action

ACE Inhibitors vs ARBs Does Cardiovascular Protection Differ

ACE Inhibitors vs ARBs Does Cardiovascular Protection Diffe

Cardiometabolism 15.09.2026

ACE Inhibitors vs ARBs Does Cardiovascular Protection Differ

Statin Intolerance Overcoming a Barrier to LDL-C Control

Dr. Maryam Al Saeed explores statin intolerance as a potential barrier to adherence, the evidence around statin safety, and the challenges of achieving lipid targets in clinical practice.

Cardiometabolism 13.09.2026

Statin Intolerance Overcoming a Barrier to LDL-C Control

1
2
3
...
8

Next